Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100515749 | 10051574 | 9 | F | 2003 | 20160928 | 20140401 | 20160930 | EXP | US-009507513-1403USA012833 | MERCK | 0.00 | F | Y | 78.46000 | KG | 20160930 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100515749 | 10051574 | 1 | PS | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 70 MG, QW | 23660 | MG | D | 20560 | 70 | MG | TABLET | /wk | |||
| 100515749 | 10051574 | 2 | SS | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | Oral | 70 MG, UNK | 0 | 70 | MG | ||||||||
| 100515749 | 10051574 | 3 | SS | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | Oral | 70 MG, UNK | 0 | 70 | MG | ||||||||
| 100515749 | 10051574 | 4 | SS | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | Oral | 70 MG, UNK | 0 | 70 | MG | ||||||||
| 100515749 | 10051574 | 5 | C | CALCIUM (UNSPECIFIED) | CALCIUM | 1 | Unknown | 600 MG, UNK | U | U | 0 | 600 | MG | ||||||
| 100515749 | 10051574 | 6 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | Unknown | 1000 IU, UNK | U | U | 0 | 1000 | IU | ||||||
| 100515749 | 10051574 | 7 | C | OMEGA-3 MARINE TRIGLYCERIDES | FISH OIL | 1 | Unknown | 1000 MG, UNK | U | 0 | 1000 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100515749 | 10051574 | 1 | Osteoporosis |
| 100515749 | 10051574 | 2 | Osteoporosis |
| 100515749 | 10051574 | 5 | Product used for unknown indication |
| 100515749 | 10051574 | 6 | Product used for unknown indication |
| 100515749 | 10051574 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100515749 | 10051574 | HO |
| 100515749 | 10051574 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100515749 | 10051574 | Benign gastric neoplasm | |
| 100515749 | 10051574 | Cataract | |
| 100515749 | 10051574 | Device loosening | |
| 100515749 | 10051574 | Fall | |
| 100515749 | 10051574 | Femur fracture | |
| 100515749 | 10051574 | Foot fracture | |
| 100515749 | 10051574 | Glaucoma | |
| 100515749 | 10051574 | Hypertension | |
| 100515749 | 10051574 | Hypothyroidism | |
| 100515749 | 10051574 | Oestrogen deficiency | |
| 100515749 | 10051574 | Osteopenia | |
| 100515749 | 10051574 | Restless legs syndrome | |
| 100515749 | 10051574 | Tendonitis | |
| 100515749 | 10051574 | Urinary tract infection | |
| 100515749 | 10051574 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100515749 | 10051574 | 1 | 20011120 | 20080505 | 0 | |
| 100515749 | 10051574 | 2 | 20080628 | 201310 | 0 | |
| 100515749 | 10051574 | 3 | 20081010 | 0 | ||
| 100515749 | 10051574 | 4 | 20081206 | 0 | ||
| 100515749 | 10051574 | 5 | 2001 | 0 | ||
| 100515749 | 10051574 | 6 | 2001 | 0 | ||
| 100515749 | 10051574 | 7 | 2001 | 0 |